Every summer, student interns descend on the NIH campuses to get some first-hand experience conducting biomedical research or learn about the administration that supports that research. The summers of 2020 and 2021 were very different.
NHLBI's Dr. Sean Agbor-Enoh had been working on a test to diagnose lung transplant rejection. When the pandemic hit, his lab sought to adapt that cell-free DNA test to predict Covid-19 outcomes. What they discovered about the level of organ and tissue injury in people with severe Covid infections is astounding. "We'd never seen anything like this," he said.
Someday, many years from now, machines may out-detect and out-diagnose physicians, but artificial intelligence will never out-care human doctors. That caring is the “secret sauce” of the medical profession, according to Dr. Eric Topol, cardiologist and award-winning scientist.
The recent Summit on Anti-SARS-CoV-2 Antibodies for Treatment and Prevention of Covid-19—Lessons Learned and Remaining Questions—identified key unanswered scientific questions to catalyze antibody clinical development and implementation.
On the Cover
3-D print of a SARS-CoV-2—the virus that causes Covid-19—particle. The virus surface (blue) is covered with spike proteins (red) that enable the virus to enter and infect human cells. The spikes on the surface of coronaviruses give this virus family its name—corona, which is Latin for “crown.” Most any coronavirus will have a crown-like appearance.